Institutional investors hold a majority ownership of AGN through the 87.21% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2017, these large investors purchased a net $16.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORTHERN TRUST GLOBAL INVESTMENT... Bought 89.2 Thousand shares of Allergan
MN SERVICES VERMOGENSBEHEER BV Bought 45.4 Thousand shares of Allergan